Cardinal Health posts $25.5 billion in Q2 revenue

DUBLIN, Ohio — Cardinal Health on Thursday reported fiscal year 2015 second-quarter revenue of $25.5 billion, including a 16% lift across its pharmaceutical segment to $22.6 billion and a 4% rise across its medical segment to $2.9 billion.

 

"We're pleased to report an excellent second quarter capping off a strong first half to our fiscal year," said George Barrett, chairman and CEO Cardinal Health. "Overall, we posted strong revenue growth for the second quarter. Although we experienced some continued challenges in the Canadian market, we saw real progress in most of our business lines and customer channels. Most important, our organization continues to drive our key strategic priorities with focus on positioning us to create new value for our customers and patients in a time of great change," he said. 

 

"Based on our performance in the first half of our fiscal year and our expectations for the second half, we are raising our guidance for full-year non-GAAP diluted EPS from continuing operations to a range of $4.28 to $4.38," Barrett added.